1247  The bacterial-derived metabolite inosine enhances cancer immunotherapy in mice.

1246  Visualization of human T lymphocyte-mediated eradication of cancer cells in vivo.

1245  ARCoV is an LNP-encapsulated mRNA vaccine platform that is highly immunogenic and safe in mice and non-human primates, conferring protection against challenge with a SARS-CoV-2 mouse-adapted strain.

1244  The bifunctional compound D18 improves checkpoint blockade efficacy by increasing KDM5A and PD-L1 abundance and inducing TLR7/8 activation.

1243  Activation of TRPA1 nociceptor promotes systemic adult mammalian skin regeneration.

1242  Lymph protects metastasizing melanoma cells from ferroptosis.

1241  An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.

1240  cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity.

1239  Potently neutralizing and protective human antibodies against SARS-CoV-2.

1238  A safeguard mechanism protects cells against aberrant immune responses toward their own genomic DNA.

Free Images for Presentation: sunipix SUNIPIX